The Role Played By Drug-Eluting Stents In Reducing Mortality In AMI
Medical News Today
5th September 2008
The safety debate about drug-eluting stents (DES) is still ongoing. In these times of uncertainty about DES safety, the study has shown that DES markedly improve long-term survival compared to modern bare-metal stents (BMS) implantation in patients with acute ST-segment elevation myocardial infarction (STEMI). In our four year investigation, DES demonstrated a significant reduction of mortality in this sick patient subset.
5th September 2008
The safety debate about drug-eluting stents (DES) is still ongoing. In these times of uncertainty about DES safety, the study has shown that DES markedly improve long-term survival compared to modern bare-metal stents (BMS) implantation in patients with acute ST-segment elevation myocardial infarction (STEMI). In our four year investigation, DES demonstrated a significant reduction of mortality in this sick patient subset.
Latest news:
1st December 2008 -
Researchers Learn That Some 'Good Cholesterol' Isn't Good Enough
1st December 2008 -
New NPS Patient Resource On Infective Endocarditis, Australia
28th November 2008 -
Opportunity to invest in a novel Acoustic Pressure Sensor for medical applications
27th November 2008 -
Medis And TomTec Launch Joint Cardiac Imaging And Analysis Product
27th November 2008 -
International Medical Team Announces Patient Results In Adult Stem Cell Clinical Study For Pulmonary Hypertension
26th November 2008 -
Why Does It Take So Long For A Correct Diagnosis Of Pulmonary Hypertension?
26th November 2008 -
Dramatic JUPITER Findings Fail To Sway Prescribing Behavior, Poll Shows
15th November 2008 -
Statement By Merck & Co., Inc., In Response To The FDA's Update Regarding A Safety Review On Bisphosphonates Including FOSAMAX®
14th November 2008 -
Arsenic May Increase Risks For Cardiovascular Disease At Current Epa-Regulated Drinking Water Standards
14th November 2008 -
High-Normal Phosphate Levels Linked To Early Atherosclerosis
